329 related articles for article (PubMed ID: 28848995)
1. Rho GTPases as therapeutic targets in cancer (Review).
Cardama GA; Gonzalez N; Maggio J; Menna PL; Gomez DE
Int J Oncol; 2017 Oct; 51(4):1025-1034. PubMed ID: 28848995
[TBL] [Abstract][Full Text] [Related]
2. [Rho GTPases as therapeutic targets in cancer and other human diseases].
Lorenzano Menna P; Cardama GA; Comin MJ; Alonso DF; Gómez DE
Medicina (B Aires); 2010; 70(6):555-64. PubMed ID: 21163747
[TBL] [Abstract][Full Text] [Related]
3. [Rho GTPases as molecular targets in cancer. Strategies and therapeutic opportunities].
Maggio J; González N; Cardama GA; Gomez DE
Medicina (B Aires); 2017; 77(6):497-504. PubMed ID: 29223942
[TBL] [Abstract][Full Text] [Related]
4. Targeting Rho GTPase signaling for cancer therapy.
Mardilovich K; Olson MF; Baugh M
Future Oncol; 2012 Feb; 8(2):165-77. PubMed ID: 22335581
[TBL] [Abstract][Full Text] [Related]
5. Approaches of targeting Rho GTPases in cancer drug discovery.
Lin Y; Zheng Y
Expert Opin Drug Discov; 2015; 10(9):991-1010. PubMed ID: 26087073
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of Rho GTPases in cancer.
Porter AP; Papaioannou A; Malliri A
Small GTPases; 2016 Jul; 7(3):123-38. PubMed ID: 27104658
[TBL] [Abstract][Full Text] [Related]
7. Rho GTPases in hematopoietic stem cell functions.
Cancelas JA; Williams DA
Curr Opin Hematol; 2009 Jul; 16(4):249-54. PubMed ID: 19417647
[TBL] [Abstract][Full Text] [Related]
8. Rho GTPases: Anti- or pro-neoplastic targets?
Zandvakili I; Lin Y; Morris JC; Zheng Y
Oncogene; 2017 Jun; 36(23):3213-3222. PubMed ID: 27991930
[TBL] [Abstract][Full Text] [Related]
9. Rho GTPases: promising cellular targets for novel anticancer drugs.
Fritz G; Kaina B
Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
[TBL] [Abstract][Full Text] [Related]
10. Rho GTPases: potential candidates for anticancer therapy.
Aznar S; Fernández-Valerón P; Espina C; Lacal JC
Cancer Lett; 2004 Apr; 206(2):181-91. PubMed ID: 15013523
[TBL] [Abstract][Full Text] [Related]
11. Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.
Sarrabayrouse G; Pich C; Teiti I; Tilkin-Mariame AF
Int J Cancer; 2017 Feb; 140(4):747-755. PubMed ID: 27616679
[TBL] [Abstract][Full Text] [Related]
12. Rho GTPases as therapeutic targets in Alzheimer's disease.
Aguilar BJ; Zhu Y; Lu Q
Alzheimers Res Ther; 2017 Dec; 9(1):97. PubMed ID: 29246246
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways: targeting the kinase effectors of RHO-family GTPases.
Prudnikova TY; Rawat SJ; Chernoff J
Clin Cancer Res; 2015 Jan; 21(1):24-9. PubMed ID: 25336694
[TBL] [Abstract][Full Text] [Related]
14. Advances in the development of Rho GTPase inhibitors.
Zhang Y; Li G; Zhao Y
Bioorg Med Chem; 2023 Jul; 90():117337. PubMed ID: 37253305
[TBL] [Abstract][Full Text] [Related]
15. Rho GTPases: Promising candidates for overcoming chemotherapeutic resistance.
Zheng CW; Zeng RJ; Xu LY; Li EM
Cancer Lett; 2020 Apr; 475():65-78. PubMed ID: 31981606
[TBL] [Abstract][Full Text] [Related]
16. Rho GTPases: functions and association with cancer.
Ellenbroek SI; Collard JG
Clin Exp Metastasis; 2007; 24(8):657-72. PubMed ID: 18000759
[TBL] [Abstract][Full Text] [Related]
17. New drug targets for pulmonary hypertension: Rho GTPases in pulmonary vascular remodelling.
Wojciak-Stothard B
Postgrad Med J; 2008 Jul; 84(993):348-53. PubMed ID: 18716013
[TBL] [Abstract][Full Text] [Related]
18. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics.
Walker K; Olson MF
Curr Opin Genet Dev; 2005 Feb; 15(1):62-8. PubMed ID: 15661535
[TBL] [Abstract][Full Text] [Related]
19. Rho GTPases and cancer.
Buongiorno P; Bapat B
Prog Mol Subcell Biol; 2005; 40():29-53. PubMed ID: 17153479
[No Abstract] [Full Text] [Related]
20. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
